Bravecto Plus Cat spot on 250 mg (2.8-6.25 kg) – one pipette

Name:
Bravecto 250 mg Plus – Spot-on pipette for cats between 2.8 – 6.25 kg

Manufacturer:
MSD

Description:
The product is an antiparasitic for small cats between (2.8 – 6.25 kg) with or at risk of mixed parasitic infestations with ticks and fleas, gastrointestinal nematodes or heartworms. Provides 12 weeks protection.

Ingredients:
Fluralaner 250 mg.
Moxidectin 12.5 mg.
Excipients: Butylhydroxytoluene 1.07 mg/ml, Dimethylacetamide, Glycofurol, Diethyltoluamide (DEET), Acetone.

Key benefits:
For the treatment of tick and flea infestations in cats, providing immediate and persistent killing of fleas (Ctenocephalides felis) and ticks (Ixodes ricinus) for 12 weeks.
Fleas and ticks need to attach to the host and start feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for flea allergy dermatitis (PAD).
For the treatment of ear mite (Otodectes cynotis) infestations.
For the treatment of intestinal roundworm infections (stage IV larvae), immature adults and adults of Toxocara cati) and hookworms (stage IV larvae, immature adults and adults of Ancylostoma tubaeforme).
When taken repeatedly every 12 weeks, the product continuously prevents heartworm disease caused by Dirofilaria immitis.
The onset of effect (killing effect) for ticks (I. ricinus) and fleas (C. felis) is within 48 hours after treatment.

Intended for:
Cats between 2.8 and 6.25 kg.

Method of administration:
Dermal administration.
Step 1: Immediately before use, open the sachet and remove the pipette. Put on the gloves. The pipette should be held by the base or the rigid upper portion under the cap in an upright position (tip up) to open it. The lid must be turned clockwise or counterclockwise for a full turn. The cap will remain on the pipette; secondment is not possible. The pipette is open and ready to apply when the seal breaks are felt.

Bravecto cat spot on how to use
Step 2: The cat should stand or lie with their back horizontal during application. Place the tip of the pipette at the base of your cat’s skull.
Step 3: Squeeze the pipette gently and apply the entire contents directly to the cat’s skin. The product should be applied to cats up to 6.25 kg in a single point at the base of the skull and in two points to cats over 6.25 kg body weight.

Form of presentation:
1 spot-on pipette.

Dosage:
1 spot-on pipette for cats between 2.8 and 6.25 kg.
For optimal control of flea infestation, the veterinary medicinal product can be administered at 12-week intervals.
For the treatment of ear mange (Otodectes cynotis) infestations, a single dose of the product should be applied. A new veterinary examination is recommended 28 days after treatment, as some animals may require additional treatment with an alternative product.

Precautions:
Ticks and fleas need to start feeding on the host in order to be exposed to the fluralaner; Therefore, the risk of transmission of parasite–borne diseases cannot be excluded.
Cats in heartworm–endemic areas (or those that have traveled to endemic areas) can be infected with adult heartworms. No therapeutic effect has been demonstrated against adult Dirofilaria immitis.
For the treatment of ear mite infections (Otodectes cynotis) or gastrointestinal nematodes T. cati and A. tubaeforme, the need and frequency of repeat treatment, as well as the choice of treatment (monosubstance or combination product) should be assessed by the treating veterinarian.

Parasite resistance to any class of anthelmintics can occur after frequent and repeated use of an anthelmintic of that class in specific circumstances.
The use of this veterinary medicinal product should be based on the assessment of each individual case and local epidemiological information on the current susceptibility of the target species in order to limit the possibility of future resistance selection.
Frequent swimming or shampooing should be avoided, as the product‘s continued effectiveness in these cases has not been tested.
Care should be taken to avoid contact of the product with the eyes of the animal.
Do not use directly on skin lesions.

In the absence of available data, treatment of cats younger than 9 weeks of age and cats of less than 1.2 kg body weight is not recommended.
Treatment of male breeding animals is not recommended.
The safety of the veterinary medicinal product has not been established during pregnancy and lactation and therefore its use in such animals is not recommended.

How to store:
Store in a place away from moisture and direct exposure to the sun, at temperatures up to 25°C.